Core Insights - The company reported a revenue of 5.3 billion yuan in the first half of 2025, marking a year-on-year growth of 31.3% [1] - Net profit attributable to shareholders reached 490 million yuan, up 28.1% year-on-year, while the net profit excluding non-recurring items was 460 million yuan, reflecting a 40.9% increase [1] - The company has consistently enhanced shareholder returns, with cumulative cash dividends and share buybacks exceeding the net amount raised from fundraising [1] Financial Performance - The consumer goods segment showed robust growth, with a revenue of 2.75 billion yuan, a year-on-year increase of 20.3% [3] - The medical segment's revenue reached 2.52 billion yuan, growing 46.4% year-on-year, driven by high-end dressings and surgical consumables [2] - The company's operating cash flow improved significantly, with a net cash flow of 340 million yuan, up 75.8% year-on-year [2] Business Segments - The consumer goods segment's key products, such as the "Nais Princess" sanitary napkins, saw a remarkable revenue increase of 67.6% to 530 million yuan [3] - The medical segment's profitability improved, with an operating profit margin of 8.6%, supported by product structure optimization and operational efficiency [2] - The company plans to focus on high-end dressings, surgical consumables, and health personal care in the medical segment, while enhancing its brand influence in the consumer goods segment [3]